» Articles » PMID: 33581919

Avidity Assay to Test Functionality of Anti-SARS-Cov-2 Antibodies

Overview
Journal Vaccine
Date 2021 Feb 14
PMID 33581919
Citations 16
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of Efficacy of Surface Coated versus Encapsulated Influenza Antigens in Mannose-Chitosan Nanoparticle-Based Intranasal Vaccine in Swine.

Bugybayeva D, Dumkliang E, Patil V, Yadagiri G, Suresh R, Singh M Vaccines (Basel). 2024; 12(6).

PMID: 38932376 PMC: 11209417. DOI: 10.3390/vaccines12060647.


Hybrid immunity in older adults is associated with reduced SARS-CoV-2 infections following BNT162b2 COVID-19 immunisation.

Pallett S, Heskin J, Keating F, Mazzella A, Taylor H, Patel A Commun Med (Lond). 2023; 3(1):83.

PMID: 37328651 PMC: 10275930. DOI: 10.1038/s43856-023-00303-y.


COVID-19 vaccines based on viral nanoparticles displaying a conserved B-cell epitope show potent immunogenicity and a long-lasting antibody response.

de Oliveira J, Zhao Z, Xiang Y, Shin M, Villasenor K, Deng X Front Microbiol. 2023; 14:1117494.

PMID: 37152732 PMC: 10157238. DOI: 10.3389/fmicb.2023.1117494.


Binding and Avidity Signatures of Polyclonal Sera From Individuals With Different Exposure Histories to Severe Acute Respiratory Syndrome Coronavirus 2 Infection, Vaccination, and Omicron Breakthrough Infections.

Singh G, Abbad A, Tcheou J, Mendu D, Firpo-Betancourt A, Gleason C J Infect Dis. 2023; 228(5):564-575.

PMID: 37104046 PMC: 10469125. DOI: 10.1093/infdis/jiad116.


The quantity and quality of anti-SARS-CoV-2 antibodies show contrariwise association with COVID-19 severity: lessons learned from IgG avidity.

Hajilooi M, Keramat F, Moazenian A, Rastegari-Pouyani M, Solgi G Med Microbiol Immunol. 2023; 212(3):203-220.

PMID: 37103583 PMC: 10133916. DOI: 10.1007/s00430-023-00763-y.


References
1.
Granoff D, Maslanka S, Carlone G, Plikaytis B, Santos G, Mokatrin A . A modified enzyme-linked immunosorbent assay for measurement of antibody responses to meningococcal C polysaccharide that correlate with bactericidal responses. Clin Diagn Lab Immunol. 1998; 5(4):479-85. PMC: 95603. DOI: 10.1128/CDLI.5.4.479-485.1998. View

2.
Demey B, Daher N, Francois C, Lanoix J, Duverlie G, Castelain S . Dynamic profile for the detection of anti-SARS-CoV-2 antibodies using four immunochromatographic assays. J Infect. 2020; 81(2):e6-e10. PMC: 7204722. DOI: 10.1016/j.jinf.2020.04.033. View

3.
Bauer G . The variability of the serological response to SARS-corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity). J Med Virol. 2020; 93(1):311-322. PMC: 7361859. DOI: 10.1002/jmv.26262. View

4.
Jiang S, Hillyer C, Du L . Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses. Trends Immunol. 2020; 41(5):355-359. PMC: 7129017. DOI: 10.1016/j.it.2020.03.007. View

5.
Benner S, Patel E, Laeyendecker O, Pekosz A, Littlefield K, Eby Y . SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors. J Infect Dis. 2020; 222(12):1974-1984. PMC: 7499592. DOI: 10.1093/infdis/jiaa581. View